297 related articles for article (PubMed ID: 16531280)
21. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
22. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
23. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
24. Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphate-polyacrylamide gel electrophoresis/Western blotting/matrix-assisted laser desorption time-of-flight mass spectrometry.
Mukai N; Nakanishi T; Shimizu A; Takubo T; Ikeda T
Ann Clin Biochem; 2008 May; 45(Pt 3):307-12. PubMed ID: 18482920
[TBL] [Abstract][Full Text] [Related]
25. [Glutamate concentration in diabetic vitreous].
Asensio Sánchez VM; Corral Azor A; Aguirre Aragón B; De Paz García M
Arch Soc Esp Oftalmol; 2003 Sep; 78(9):493-7. PubMed ID: 14517736
[TBL] [Abstract][Full Text] [Related]
26. Changes in adrenomedullin in patients with proliferative diabetic retinopathy.
Lu Y; Xu Y; Tang C
Curr Eye Res; 2011 Nov; 36(11):1047-52. PubMed ID: 21942228
[TBL] [Abstract][Full Text] [Related]
27. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
[TBL] [Abstract][Full Text] [Related]
28. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
Liinamaa MJ; Savolainen MJ
Ann Med; 2008; 40(3):209-14. PubMed ID: 18382886
[TBL] [Abstract][Full Text] [Related]
29. Increased osteopontin levels in the vitreous of patients with diabetic retinopathy.
Kase S; Yokoi M; Saito W; Furudate N; Ohgami K; Kitamura M; Kitaichi N; Yoshida K; Kase M; Ohno S; Uede T
Ophthalmic Res; 2007; 39(3):143-7. PubMed ID: 17505146
[TBL] [Abstract][Full Text] [Related]
30. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the protein pattern in physiologic and pathologic vitreous bodies by electrophoresis and immunologic identification].
Bresgen M; Martiny B; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1991; 88(6):665-70. PubMed ID: 1794787
[TBL] [Abstract][Full Text] [Related]
33. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
34. [Contribution of posterior hyaloid membrane to pathogenesis and transciliary surgery of proliferative diabetic retinopathy].
Sdobnikova SV; Stoliarenko GE
Vestn Oftalmol; 1999; 115(1):11-3. PubMed ID: 10232994
[TBL] [Abstract][Full Text] [Related]
35. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
[TBL] [Abstract][Full Text] [Related]
36. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
37. Angiopoietin concentrations in diabetic retinopathy.
Patel JI; Hykin PG; Gregor ZJ; Boulton M; Cree IA
Br J Ophthalmol; 2005 Apr; 89(4):480-3. PubMed ID: 15774928
[TBL] [Abstract][Full Text] [Related]
38. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases.
Yoneda S; Hara H; Hirata A; Fukushima M; Inomata Y; Tanihara H
Jpn J Ophthalmol; 2005; 49(2):106-8. PubMed ID: 15838725
[TBL] [Abstract][Full Text] [Related]
39. [Proteomics in clinical research: new approach of mass spectrometry].
Shimizu A; Nakanishi T; Koyama R; Ikeda T
Rinsho Byori; 2002 Feb; 50(2):169-72. PubMed ID: 11925855
[TBL] [Abstract][Full Text] [Related]
40. [Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy].
Asensio-Sánchez VM; Gómez-Ramírez V; Morales-Gómez I
Arch Soc Esp Oftalmol; 2008 Mar; 83(3):169-72. PubMed ID: 18311675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]